UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 71 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $162,000 | +161.3% | 405,500 | +271.2% | 0.00% | – |
Q2 2022 | $62,000 | -78.0% | 109,251 | -56.5% | 0.00% | – |
Q1 2022 | $282,000 | -77.4% | 251,295 | -70.7% | 0.00% | – |
Q4 2021 | $1,250,000 | +67.1% | 856,442 | +243.5% | 0.00% | – |
Q3 2021 | $748,000 | +32.9% | 249,342 | +105.4% | 0.00% | – |
Q2 2021 | $563,000 | -49.2% | 121,411 | -34.3% | 0.00% | – |
Q1 2021 | $1,109,000 | -20.8% | 184,750 | -30.8% | 0.00% | – |
Q4 2020 | $1,400,000 | +255.3% | 266,908 | +134.4% | 0.00% | – |
Q3 2020 | $394,000 | +13.2% | 113,883 | +184.1% | 0.00% | – |
Q2 2020 | $348,000 | +86.1% | 40,082 | +24.2% | 0.00% | – |
Q1 2020 | $187,000 | +122.6% | 32,264 | +134.5% | 0.00% | – |
Q3 2019 | $84,000 | -74.7% | 13,757 | -60.6% | 0.00% | – |
Q2 2019 | $332,000 | +242.3% | 34,908 | +193.3% | 0.00% | – |
Q1 2019 | $97,000 | -45.2% | 11,900 | +9.0% | 0.00% | – |
Q4 2018 | $177,000 | – | 10,915 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund V Management, LLC | 491,751 | $275,000 | 2.22% |
GSA CAPITAL PARTNERS LLP | 639,937 | $361,000 | 0.05% |
PURA VIDA INVESTMENTS, LLC | 359,089 | $202,000 | 0.01% |
Caption Management, LLC | 725,000 | $409,000 | 0.01% |
Forefront Analytics, LLC | 20,377 | $11,000 | 0.01% |
Johnson Midwest Financial, LLC | 6,100 | $3,000 | 0.00% |
Virtu Financial LLC | 62,640 | $35,000 | 0.00% |
Caption Management, LLC | 225,000 | $127,000 | 0.00% |
SeaCrest Wealth Management, LLC | 25,000 | $14,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 191,450 | $108,000 | 0.00% |